Agreement addresses all requests by President Trump to reduce drug costs in the U.S., encourage global investment and protect ...

Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...

Neuraworx Medical Technology, Inc., a neurotechnology company developing first-in-class bioelectronic solutions for brain ...

Boards and executive buyers are raising the 2026 bar for all product and service rankings and this annual statement explains the standards Black Book applies to keep survey evaluations rigorous, ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a ...

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite holding FDA Orphan Drug Designations, passing multiple DEA inspections, being awarded a DEA ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in ...

Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a ...

CHICAGO, IL / ACCESS Newswire / December 19, 2025 / For a long stretch, Cosmos Health (NASDAQ:COSM) sat in a familiar category. A company investors respected, followed, and occasionally revisited, but ...

STOCKHOLM, SE / ACCESS Newswire / December 19, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) ...

Sermo Barometer reveals shifting access pathways, evolving prescribing behavior, and long-term impacts on patient care.NEW ...

Global Cellular Health Screening Market OverviewThe global cellular health screening market was valued at approximately US$ 2 ...